AORT (Artivion) EBIT per Share : $0.58 (TTM As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Artivion EBIT per Share?

Artivion's EBIT per Share for the three months ended in Dec. 2024 was $-0.16. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.58.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Artivion's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Artivion was 102.50% per year. The lowest was -35.00% per year. And the median was 2.00% per year.

AORT's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 5.65
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Artivion's EBIT for the three months ended in Dec. 2024 was $-6.9 Mil.

Artivion EBIT per Share Historical Data

The historical data trend for Artivion's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion EBIT per Share Chart

Artivion Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.01

0.05

0.08

0.09

0.64

Artivion Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															0.14	0.43	0.14	0.17	-0.16

Artivion EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Artivion's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	26.763	/	41.676
=	0.64

Artivion's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.86	/	41.883
=	-0.16

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.58

Artivion (NYSE:AORT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Artivion EBIT per Share Related Terms

Thank you for viewing the detailed overview of Artivion's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Artivion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CYL:Germany CYL:Germany

Address

1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144

Website

https://www.artivion.com

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Executives

Jean F Holloway	officer: VP, General Counsel	C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
John E Davis	officer: Senior VP, Global Sales	1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Marshall S. Stanton	officer: SVP, Clinical & MD Affair	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Amy Horton	officer: Chief Accounting Officer	C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
James P Mackin	officer: President & CEO	ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Anthony B. Semedo	director	3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Andrew M Green	officer: VP Regulatory	ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
Matthew A Getz	officer: VP, Human Resources	1655 ROBERTS BLVD NW, KENNESAW GA 30144
Rochelle L. Maney	officer: VP, Quality	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Florian Tyrs	officer: VP, Global Operations	IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson	officer: VP Research & Development	33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Dennis B Maier	officer: Vice President, Operations	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
David Ashley Lee	officer: Executive VP, COO & CFO	C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff	director	2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Ronald D Mccall	director	C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144